Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZL-1102 gel in chronic plaque psoriasis (Phase II)
CTR20244768Phase 2Terminated
- Sponsor
- Zai Lab
- Start
- Dec 2024
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of ZL-1102 in psoriasis, sponsored by Zai Lab. Started Dec 2024; status: terminated.
02
Drugs
ZL-1102
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20244768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244768.